15 /100
LOW RISK
Score updated May 29, 2026

BDTX — Black Diamond Therapeutics, Inc. Dilution Risk Tracker

Track BDTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BDTX.
🔔 Track BDTX — Get forecast alerts →

💹 Market Data

Market Cap$128.93M
Shares Outstanding57.30M
Float46.26M
Cash$118.26M
Debt$17.88M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.6% shares (2025Q4 vs prior)
103 institutional holders · 40.52M shares
#1 T. Rowe Price Investment Management, Inc. 12.94M shares
#2 NEA Management Company, LLC 4.45M shares
#3 VANGUARD GROUP INC 2.19M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.48M
Days to Cover5.3
% of Float9.7%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
xbrl XBRL WARRANT Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track BDTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for BDTX
📊 BDTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BDTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.